Related Experiment Video
Updated: Jul 31, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Strategy for diagnosis and management in iron overload
1Servicio de Medicina de Aparato Digestivo. Hospital Universitario 12 de Octubre. Madrid. Spain. jsolis.hdoc@salud.madrid.org
Diagnosing iron overload involves checking transferrin saturation and serum ferritin levels. Genetic testing for HFE mutations confirms hereditary hemochromatosis, guiding treatment with phlebotomy or chelating agents.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Iron overload conditions require accurate diagnosis and management.
- Hereditary hemochromatosis is a common genetic disorder leading to excess iron accumulation.
Purpose of the Study:
- To outline diagnostic criteria for iron overload.
- To differentiate hereditary hemochromatosis from other causes.
- To guide treatment strategies based on diagnosis and patient condition.
Main Methods:
- Measuring transferrin saturation and serum ferritin levels.
- Performing HFE protein genotyping (C282Y, H63D).
- Assessing iron overload severity and organ damage, potentially via liver biopsy.
Main Results:
- Transferrin saturation >45% and elevated serum ferritin indicate iron overload.
- Specific HFE genotypes confirm hereditary hemochromatosis.
- Treatment decisions depend on anemia presence and iron levels, with phlebotomy or chelating agents used.
Conclusions:
- Early diagnosis of iron overload is crucial.
- HFE genotyping is key for identifying hereditary hemochromatosis.
- Tailored treatment approaches improve patient outcomes.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Myocarditis IV: Nursing Management
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy VI: Nursing Management

